Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Manises – page 2

71 clinical trials in Manises, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Manises at a glance
71
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

71 trials in Manises

Open in trial search
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Colorado Prevention Center

Weaning failure

Recruiting

Study Comparing Non-Invasive Ventilation and High Flow Oxygen Therapy for Patients at Risk of Breathing Support Failure After Ventilator Removal

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Dermatitis atopic+1

Not yet recruiting

Long-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Lebrikizumab
  • Sponsor:Eli Lilly & Co.

Dermatitis atopic

Not yet recruiting

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:IMG-007
  • Sponsor:Inmagene LLC

Psoriasis

Not yet recruiting

Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Janssen Cilag International

IgA nephropathy

Not yet recruiting

Study of ARGX-121 to Reduce Proteinuria in Adults with Primary IgA Nephropathy (IgAN)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Argenx

Dermatitis atopic

Not yet recruiting

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pegcetacoplan
  • Sponsor:Apellis Pharmaceuticals Inc.

Psoriasis

Not recruiting

Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Dermatitis atopic

Not recruiting

Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Manises

What the registry says about research in the country

01 Dermatological Conditions

Innovative clinical trials focusing on plaque psoriasis and atopic dermatitis, evaluating new therapeutic approaches for moderate to severe cases.

  • Psoriasis Treatment Studies
  • Atopic Dermatitis Management
  • Long-term Safety Evaluations

Multiple studies investigating novel compounds and treatment options for chronic skin conditions.

02 Inflammatory Disorders

Comprehensive research into hidradenitis suppurativa, examining various therapeutic agents for managing this challenging condition.

  • Novel Treatment Approaches
  • Disease Management Strategies
  • Patient Response Assessment

Studies aim to improve quality of life for patients with chronic inflammatory conditions.

03 Specialized Conditions

Research targeting specific conditions including prurigo nodularis, vitiligo, and chronic spontaneous urticaria.

  • Innovative Therapies
  • Symptom Management
  • Treatment Efficacy Studies

Focused investigations on targeted treatments for specific dermatological conditions.

04 Cardiovascular Health

Studies examining treatments for heart failure and related conditions, with emphasis on combination therapies and patient outcomes.

  • Heart Failure Management
  • Therapeutic Combinations
  • Clinical Outcomes Research

Investigations into improving cardiovascular health through innovative treatment approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.